Understanding influenza vaccination behaviors: A comprehensive sociocultural framework

Expert Review of Vaccines

Volumn 13, Issue 1, 2014, Pages 17-29

  Ward, Jeremy ^a   Raude, Jocelyn ^b,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b French School of Public Health (EHESP)   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

Author keywords

influenza; sociocultural and psychological determinants; vaccination behaviors

Indexed keywords

INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; THIOMERSAL; WART VIRUS VACCINE;

2009 H1N1 INFLUENZA; AGE; ATTITUDE TO HEALTH; COGNITION; CULTURAL ANTHROPOLOGY; CULTURAL COGNITION PROJECT; CULTURAL FACTOR; EDUCATIONAL STATUS; HEALTH BEHAVIOR; HEALTH CARE ACCESS; HEALTH SURVEY; HUMAN; IMMUNIZATION; INCOME; INDIVIDUALITY; INFECTION; INFLUENZA; INFLUENZA A (H1N1); INFLUENZA VACCINATION; MARY DOUGLAS THEORY OF RISK PERCEPTION; METHODOLOGY; MODEL; PANDEMIC INFLUENZA; PERCEPTION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL THEORY; PSYCHOMETRY; QUANTITATIVE STUDY; RACE DIFFERENCE; REVIEW; RISK; SEASONAL INFLUENZA; SEX DIFFERENCE; SOCIAL STRUCTURE; SOCIOECONOMICS; VACCINATION;

HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; PATIENT ACCEPTANCE OF HEALTH CARE; VACCINATION;

EID: 84893122796     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.2014.863156     Document Type: Review

References (118)

1. Carrat F, Sahler C, Rogez S et al. Influenza burden of illness: estimates from a national prospective survey of household contacts in France. Arch. Intern. Med. 162(16), 1842-1848 (2002).
2. Viboud C, Pakdaman K, Boelle PY et al. Association of influenza epidemics with global climate variability. Eur. J. Epidemiol. 19(11),1055-1059 (2004).
3. Thompson WW, Weintraub E, Dhankhar P et al. Estimates of US influenza-associated deaths made using four different methods. Influenza Other Respir. Viruses 3(1), 37-49 (2009).
4. Lemaitre M, Carrat F, Rey G, Miller M, Simonsen L, Viboud C. Mortality burden of the 2009 A/H1N1 influenza pandemic in France: comparison to seasonal influenza and the A/H3N2 pandemic. PLoS ONE 7(9), e45051 (2012).
5. Viboud C, Boelle PY, Pakdaman K, Carrat F, Valleron AJ, Flahault A. Influenza epidemics in the United States, France, and Australia, 1972-1997. Emerg. Infect. Dis. 10(1), 32-39 (2004).
6. Carrat F, Valleron AJ. Influenza mortality among the elderly in France, 1980-90: how many deaths may have been avoided through vaccination? J. Epidemiol. Community Health 49(4), 419-425 (1995).
7. Centers for Disease Control and Prevention. Estimates of deaths associated with seasonal influenza -United States, 1976-2007. MMWR Morb. Mortal. Wkly Rep. 59(33), 1057-1062 (2010).
8. InVS. Le Calendrier des vaccinations et les recommandations vaccinales 2013 selon l'avis du Haut Conseil de la santé publique. BEH 14-15, 129-160 (2013).
9. Assemblée parlementaire du Conseil de l'Europe. La gestion de la pandémie H1N1: nécessité de plus de transparence. Résolution
10. Sénat. Rapport N°685 de la commission d'enquête sur le rôle des firmes pharmaceutiques dans la gestion par le Gouvernement de la grippe A (H1N1), 29 Juillet 2010.
11. Barker C. Cultural Studies: Theory and Practice (3rd Edition). Sage, London, UK (2008).
12. Weinstein ND. Testing four competing theories of health-protective behavior. Health Psychol. 12(4), 324-333 (1993).
13. Ouellette JA, Wood W. Habit and intention in everyday life: the multiple processes by which past behavior predicts future behavior. Psychol. Bull. 124(1), 54-74 (1998).
14. Van der Wouden JC, Bueving HJ, Poole P. Preventing influenza: an overview of systematic reviews. Respir. Med. 99(11), 1341-1349 (2005).
15. Weinstein ND, Kwitel A, McCaul KD, Magnan RE, Gerrard M, Gibbons FX. Risk perceptions: assessment and relationship to influenza vaccination. Health Psychol. 26(2), 146-151 (2007).
16. Rosenstock IM. What research in motivation suggests for public health. Am. J. Public Health. 50(3), 295-302 (1960).
17. Philipson T. Private vaccination and public health: an empirical examination for US measles. J. Hum. Resour. 31, 611-630 (1996).
18. Reluga TC, Bauch C, Galvani AP. Evolving public perceptions and stability in vaccine uptake. Math. Biosci. 204, 185-198 (2006).
19. Brewer NT, Chapman GB, Gibbons FX, Gerrard M, McCaul KD, Weinstein ND. Meta-analysis of the relationship between risk perception and health behavior: the example of vaccination. Health Psychol. 26(2), 136-145 (2007).
20. Cummings KM, Jette AM, Brock BM, Haefner DP. Psychosocial determinants of immunization behavior in a swine influenza campaign. Med. Care 17(6), 639-649 (1979).
21. Chapman GB, Coups EJ. Predictors of influenza vaccine acceptance among healthy adults. Prev. Med. 29, 249-262 (1999).
22. Bish A, Yardley L, Nicoll A, Michie S. Factors associated with uptake of vaccination against pandemic influenza: a systematic review. Vaccine 29 (38), 6472-6484 (2011).
23. Alhakami AS, Slovic P. A psychological study of the inverse relationship between perceived risk and perceived benefit. Risk Anal. 14(6), 1085-1096 (1994).
24. Brien S, Kwong JC, Buckeridge DL. The determinants of 2009 pandemic A/ H1N1 influenza vaccination: a systematic Review. Vaccine 30, 1255-1264 (2012).
25. Maurer J. Harris KM, Parker A, Lurie N. Does receipt of seasonal influenza vaccine predict intention to receive novel H1N1 vaccine: Evidence from a nationally representative survey of U.S. adults. Vaccine 27(42), 5732-5734 (2009).
26. Poland GA. The 2009-2010 influenza pandemic: effects on pandemic and seasonal vaccine uptake and lessons learned for seasonal vaccination campaigns. Vaccine 28 (Suppl. 4(0)), D3-D13 (2010).
27. Finucane ML, Slovic P, Mertz CK, FlynnJ, Satterfield TA. Gender, race, and perceived risk: the 'white male' effect. Health Risk Soc. 2(2), 159-172 (2000).
28. Slovic P. Trust, emotion, sex, politics, and science: surveying the risk assessment battlefield. Risk Anal. 19(4), 689-701 (1999).
29. Palmer C. Risk perception: another look at the 'white male' effect. Health Risk Soc. 5(1), 71-83 (2003).
30. Coupland C, Harcourt S, Vinogradova Y et al. Inequalities in uptake of influenza vaccine by deprivation and risk group: time trends analysis. Vaccine 25(42), 7363-7371 (2007).
31. Nagata M, Hernandez-Ramos I, Sivasankara Kurup A, Albrecht D, Vivas-Torrealba C, Franco-Paredes C. Social determinants of health and seasonal influenza vaccination in adults >=65 years: a systematic review of qualitative and quantitative data. BMC Public Health 13, 388-438 (2013).
32. Endrich MM, Blank PR, Szucs TD. Influenza vaccination uptake and socioeconomic determinants in 11 European countries. Vaccine 27, 4018-4024 (2009).
33. Bobo JK, Gale JL, Thapa PB, Wassilak SG. Risk factors for delayed immunization in a random sample of 1163 children from Oregon and Washington. Pediatrics 91(2), 308-314 (1993).
34. Danis K, Georgakopoulou T, Stavrou T, Laggas D, Panagiotopoulos T. Socioeconomic factors play a more important role in childhood vaccination coverage than parental perceptions: a cross-sectional study in Greece. Vaccine 28, 1861-1869 (2010).
35. Nowalk MP, Zimmerman RK, Shen S, Jewell IK, Raymund M. Barriers to pneumococcal and influenza vaccination in older community-dwelling adults (2000-2001). J. Am. Geriatr. Soc. 52(1), 25-30 (2004).
36. Shemesh AA, Rasooly I, Horowitz P et al. Health behaviors and their determinants in multiethnic, active Israeli seniors. Arch. Gerontol. Geriatr. 47(1), 63-77 (2008).
37. O'Malley AS, Forrest CB. Immunization disparities in older Americans: determinants and future research needs. Am. J. Prev. Med. 31(2), 150-158 (2006).
38. Zimmerman RK, Mieczkowski TA, Wilson SA. Immunization rates and beliefs among elderly patients of inner city neighborhood health centers. Health Promot. Pract. 3(2), 197-206 (2002).
39. Bardenheier BH, Wortley PM, Winston CA, Washington ML, Lindley MC, Sapsis K. Do patterns of knowledge and attitudes exist among unvaccinated seniors? Am. J. Health Behav. 30(6), 675-683 (2006).
40. Zimmerman RK, Santibanez TA, Janosky JE et al. What affects influenza vaccination rates among older patients? An analysis from inner-city, suburban, rural, and veterans affairs practices. Am. J. Med. 114(1), 31-38 (2003).
41. Lindley MC, Groom AV, Wortley PM, Euler GL. Status of influenza and pneumococcal vaccination among older American Indians and Alaska Natives. Am. J. Public Health 98(5), 932-938 (2008).
42. Handbook of Health Behavior Research I: Personal and Social Determinants. Gochman DS (Ed.). Plenum Press, NY, USA (1997).
43. Damiani G, Federico B, Visca M, Agostini F, Ricciardi W. The impact of socioeconomic level on influenza vaccination among Italian adults and elderly: a crosssectional study. Prev. Med. 45(5), 373-379 (2007).
44. Sarri'a-Santamera A, Timoner J. Influenza vaccination in old adults in Spain. Eur. J. Pub. Health 13(2), 133-137 (2003).
45. Pena-Rey I, Perez-Farinos N, Sarr?-a-Santamera A. Factors associated with influenza vaccination among elderly Spanish women. Public Health 118(8), 582-587 (2004).
46. De Andres AL, Garrido PC, Herna'ndez-Barrera V, Del Pozo SV, De Miguel A ́ G, Jime'nez-Garci'a R. Influenza vaccination among the elderly Spanish population: trend from 1993 to 2003 and vaccination-related factors. Eur. J. Pub. Health 17(3), 272-277 (2007).
47. Lahelma E. Health and social stratification. In: The New Blackwell Companion to Medical Sociology. Cockerham WC (Ed.). Wiley-Blackwell, Oxford, UK, 71-96 (2010).
48. Cockerham WC. Health lifestyles: bringing culture back. In: The New Blackwell Companion to Medical Sociology. Cockerham WC (Ed.). Wiley-Blackwell, Oxford, UK, 159 (2010).
49. Bourdieu P. Distinction: A Social Critique of the Judgement of Taste. Harvard University Press, Cambridge, USA (1984).
50. Quah S. Health and Culture. In: The New Blackwell Companion to Medical Sociology. Cockerham WC. (Ed.). Wiley-Blackwell, Oxford, UK, 27-46 (2010).
51. Chiatti C, Di Rosa M, Barbadoro P, Lamura G, Di Stanislao F, Prospero E. Socioeconomic determinants of influenza vaccination among older adults in Italy. Prev. Med. 51(3-4), 332-333 (2010).
52. Link BG, Phelan J. Social conditions as fundamental causes of disease. J. Health Soc. Behav. (Spec), 80-94 (1995).
53. Kwong EW, Lam IO. Chinese older people in Hong Kong: health beliefs about influenza vaccination. Nurs. Older People 20(7), 29-33 (2008).
54. Mangtani P, Breeze E, Kovats S, Ng ESW, Roberts JA, Fletcher A. Inequalities in influenza vaccine uptake among people aged over 74 years in Britain. Prev. Med. 41(2), 545-553 (2005).
55. Sturgis P, Allum N. Science in Society: re-evaluating the deficit model of public attitudes. Public Underst. Sci. 13, 55-74 (2004).
56. Weinstein ND, Klein WM. Resistance of personal risk perceptions to debiasing interventions. Health Psychol. 14(2), 132-140 (1995).
57. Kahneman D, Slovic P, Tversky A. Judgment Under Uncertainty: Heuristics and Biases. Cambridge University Press, NY, USA (1982).
58. Heuristics: The foundations of Adaptive Behavior. Gigerenzer G., Hertwig R, Pachur T (Eds). Oxford University Press, NY, USA (2011).
59. Gigerenzer G, Brighton H. Homo heuristicus: why biased minds make better inferences. Top. Cogn. Sci. 1, 107-143 (2009).
60. Gigerenzer G, Todd P; the ABC Group. Simple Heuristics That Make us Smart. Oxford University Press, New York, USA (1999).
61. Slovic P, Fischhoff B, Lichtenstein S. Rating the risks. Environment 21(3), 14-39 (1979).
62. Slovic P. Perceived risk, trust, and democracy. Risk Anal. 13(6), 675-682 (1993).
63. Macintyre S. The Black Report and beyond: what are the issues? Soc. Sci. Med. 44(6), 723-745 (1997).
64. Vasterman P, Yzermans, C.J. Dirkzwager AJE. The role of the media and media hypes in the aftermath of disasters. Epidemiol. Rev. 27, 107-114 (2005).
65. Freed G L, Clark SJ, Butchart AT, Singer DC, Davis MM. Sources and perceived credibility of vaccine-safety information for parents. Pediatrics 27(Suppl. 1), S107-S112 (2011).
66. Gangarosa EJ, Galazka AM, Wolfe CR et al. Impact of anti-vaccine movements on pertussis control: the untold story. Lancet 351(9099), 356-361 (1998).
67. Setbon M, Raude J. Factors in vaccination intention against the pandemic influenza A/ H1N1. Eur. J. Public Health 20(5), 490-494 (2010).
68. Raude J, Caille-Brillet AL, Setbon M. The pandemic H1N1 influenza vaccination in France: who accepted to receive the vaccine and why? PLoS Curr. 2, RRN118 (2010).
69. Gallup. Eurobarometer: Influenza H1N1 Analytical Report. Flash EB #287 (2010).
70. Boykoff, MT, Boykoff JM. Balances as bias: global warming and the U.S. prestige press. Global Environ. Change 14, 125-136 (2004).
71. Smith, J. Dangerous news: media decision making about climate change risk. Risk Anal. 25(6), 1471-1482 (2005).
72. Clarke CE. Question of Balance: the autism-vaccine controversy in the British and American Elite press. Sci. Commun. 30, 77-108 (2008).
73. Dixon G, Clarke C. The effect of falsely balanced reporting of the autism-vaccine controversy on vaccine safety perceptions and behavioral intentions. Health Educ. Res. 28(2), 352-359 (2013).
74. Fonteneau L, Guthmann JP, Le'vy-Bruhl D. Estimation des couvertures vaccinales en France a partir de l'E ́ chantillon ge'ne'raliste des be'ne'ficiaires (EGB): exemples de la rougeole, de l'he'patite B et de la vaccination HPV. Bull. Epidemiol. Hebd. 8-9,72-76 (2013).
75. Antona D, Lévy-Bruhl D, Baudon C et al. Measles elimination efforts and 2008-2011 outbreak in France. Emerg. Infect. Dis. (19) 357-364 (2013).
76. Callon M, Lascoumes P, Barthe Y. Acting in an Uncertain World. An Essay on Technical Democracy. The MIT Press, Cambridge, USA (2009).
77. McMillen CW, Brimnes N. Medical modernization and medical nationalism: resistance to mass tuberculosis vaccination in postcolonial India, 1948-1955. Comp. Stud. Soc. Hist. 52(1), 180-209 (2010).
78. Porter D, Porter R. The politics of prevention: antivaccinationism and public health in nineteenth century England. Med. Hist. 32, 23152 (1988).
79. Wolfe RM, Sharp LK. Acts of faith: religion, medicine, and the antivaccination movement. Park Ridge Center Bull. (2000).
80. Wolfe RM, Sharp LK. Anti-vaccinationists past and present. BMJ 325(7361), 430-432 (2002).
81. Durbach N. Bodily Matters: The Anti-Vaccination Movement in England, 1853-1907. Duke University Press, Durham, USA (2004).
82. Fressoz JB. Beck Back in the 19th century: towards a genealogy of risk society. Hist. Technol. 23(4), 333-350 (2007).
83. Hobson-West P. Understanding vaccination resistance: moving beyond risk. Health Risk Soc. 5(3), 273-283 (2003).
84. Simpson N, Lenton S, Randall R. Parental refusal to have children immunised: extent and reasons, BMJ 310, 225-227 (1995).
85. Hobson-West P. The construction of lay resistance to vaccination. In: Constructions of Health and Illness: European Perspectives. Shaw I, Kaupinen K (Eds). Ashgate Press, Aldershot, UK (2004).
86. Fressoz JB. L'apocalypse joyeuse: une Histoire du Risque Technologique. Seuil, Paris, France (2012).
87. Medicines: Meanings & Contexts. Etkin NL, Tan ML (Eds). Health Action Information Network, Quezon City, USA (1994).
88. The Context of Medicines in Developing Countries. Van der Geest S, Reynolds-Whyte S (Eds). Kluwer, Utrecht, the Netherlands (1989).
89. Streefland PH, Chowdhury AM, Ramos-Jimenez P. Quality of vaccination services and social demand for vaccinations in Africa and Asia. Bull. World Health Organ. 77(9),722-730 (1999).
90. Coulter A. The Autonomous Patient: Ending Paternalism in Medical Care. The Nuffield Trust, London, UK (2002).
91. Guadagnoli E. Ward P. Patient participation in decision-making. Soc. Sci. Med. 47, 329-339 (1998).
92. British Department of Health. Building on the Best: Choice, Responsiveness and Equity in the NHS. Departement of Health, London, UK (2003).
93. Britten N, Stevenson F, Gafaranga J, Barry C, Bradley C. The Expression of aversion to medicines in general practice consultations. Soc. Sci. Med. 59(7), 1495-1503 (2004).
94. Lupton D. Consumerism, reflexivity and the medical encounter. Soc. Sci. Med. 45(3), 373-381 (1997).
95. Blank PR, Schwenkglenks M, Szucs TD. Influenza vaccination coverage rates in five European countries during season 2006/ and trends over six consecutive seasons. BMC Public Health 8, 272 (2008).
96. Schwarzinger M, Verger P, Guerville MA et al. Positive attitudes of French general practitioners towards A/H1N1 influenza-pandemic vaccination: a missed opportunity to increase vaccination uptakes in the general public? Vaccine 28, 2743-2748 (2010).
97. Henwood F, Wyatt S, Hart A. Smith J. Ignorance is bliss sometimes: constraints on the emergence of the informed patient in the changing landscape of health information. Sociol. Health Illn. 25(6), 589-607 (2003).
98. Bakx K. The 'Eclipse' of folk medicine in western society. Sociol. Health Illn. 13(1), 20-38 (1991).
99. Sharma U. Complementary Medicine Today: Practitioners and Patients. Routledge, London, UK (1992).
100. Siahpush M. A critical review of the sociology of alternative medicine: research on users, practitioners and the orthodoxy. Health 4(2), 159-178 (2000).
101. Williams S. Calnan M. Modern Medicine: Lay Perspectives and Experiences. UCL Press, London, UK (1996).
102. Pound P, Britten N, Morgan M et al. Resisting medicines: a synthesis of qualitative studies of medicine taking. Soc. Sci. Med. 61, 133-155 (2005).
103. Nettleton S. The Sociology of Health and Illness. Polity Press, Cambridge, UK (2006).
104. Kahan D. Cultural cognition as a conception of the cultural theory of risk. In: Handbook of Risk Theory. Roeser S, Hillerbrand R, Sandin P, Peterson M (Eds). Springer, New Haven, USA, 725-759 (2012).
105. Handbook of Cultural Psychology. Kitayama S, Cohen D (Eds). Guilford Press, New York, USA (2010).
106. Douglas M, Wildavsky AB. Risk and culture: An Essay on the Selection of Technical and Environmental Dangers. University of California Press, Berkeley, USA (1982).
107. Douglas M. Risk and Blame: Essays in Cultural Theory. Routledge, New York, USA (1992).
108. Thompson M, Grenstadt G, Selle P. Cultural Theory as Political Science. Routledge, London, UK (1999).
109. Manzi T, Jacobs K. Understanding institutions, actors and networks: advancing constructionist methods in urban policy research. In: Qualitative Urban Analysis: An International Perspective (Studies in Qualitative Methodology, Volume 9). Maginn PJ, Thompson SM, Tonts M (Eds). Emerald, Bingley, UK, 29-50 (2008).
110. Kahan D, Braman D, Gastil J, Slovic P, Mertz CK. Culture and identity-protective cognition: explaining the White-male effect in risk perception. J. Empirical Legal Stud. 4(3), 465-505 (2007).
111. Kahan D, Braman D. More statistics, less persuasion: a cultural theory of gun-risk perceptions. U. Pa. L. Rev. 151, 1291-1327 (2003).
112. Kahan D. Why we are poles apart on climate change. Nature 488(255) (2012).
113. Kahan D, Jenkins-Smith H, Braman D. Cultural cognition of scientific consensus. J. Risk Res. 14, 147-174, (2011).
114. Kahan DM, Braman D, Cohen GL, Gastil J, Slovic P. Who fears the HPV vaccine, who doesn't, and why? An experimental study of the mechanisms of cultural cognition. Law. Hum. Behav. 34(6), 501-516 (2010).
115. Berkman LF, Glass T, Brissette I, Seeman TE. From social integration to health: Durkheim in the new millennium. Soc. Sci. Med. 51(6), 843-857 (2000).
116. WHO. Seasonal influenza. Fact sheet N° 211, April 2009. www.who.int/mediacentre/factsheets/fs211/ en/index.html (Accessed 24 April 2013)
117. Commission of The European Communities. Council recommendation on seasonal influenza vaccination. Brussels, Belgium (2009). http://ec.europa.eu/ health/ph-threats/com/ Influenza/docs/seasonflu-rec2009-en.pdf (Accessed 24 April 2013)
118. Kahan D. What Generalizes and what doesn't? Cultural Cognition blog, (2012). www.culturalcognition.net/ blog/2012/7/12/what-generalizes-whatdoesnt- cross-cultural-cultural-cogniti. html